EHSI to Launch the First of Several Medical iPhone Apps

Emerging Healthcare Solutions, Inc. (PinkSheets:EHSI) announced today that the Company is scheduling their e-911 iPhone App to be available for public access downloading in the coming several days. This move establishes the e-911 app as the first of multiple dynamic medical iPhone apps the Company is planning for roll out. The potentially lifesaving e-911 app is designed to make critical medical information available to first responders in the event that 911 is dialed from the phone. Critical medical information, medical conditions and contact information can assist emergency medical personnel to administer effective treatments more quickly in situations where every second is critical.

Currently, the Company still has under development their MedAnywhere comprehensive Medical app and associated modules. The first MedAnywhere module scheduled for completion is the MedAnywhere HHC Hematocrit monitoring app, which the company believes will be complete later this month. The Company is also developing AutoMed, which is an app that alerts people with multiple prescriptions of the correct time and dosage of the drugs they have been prescribed; RXAssist, which is an app aimed at helping people find discounts and free prescription drug support; and AltMedFacts, which is an app that is being designed to help the user find stem cell and alternative medical treatment centers outside of the USA.

EHSI will initially offer the e-911 for exclusive use on the Apple iPhone (NASDAQ:AAPL). After assuring product quality, the Company plans to make the e-911 available for Google’s Android (NASDAQ: GOOG) and Research in Motion’s BlackBerry (NASDAQ:RIMM) devices. The Company has set a goal for the e-911 at one million downloads in the first year of its release. The application will also be made available on the Company’s website at www.emerginghealthcaresolutionsinc.com.

According to Apple, more than three billion applications have been downloaded from its App Store by iPhone and iPod touch users worldwide. Such demand has instilled confidence within EHSI that e-911 will enter a market primed and ready for its release.

Emerging Healthcare Solutions, Inc. strives to develop cutting-edge medical technology that displays potential to produce significant returns. The Houston-based company competes in the emerging medical technology sector that includes companies such as Johnson & Johnson (NYSE:JNJ).

About Emerging Healthcare Solutions, Inc.

Emerging Healthcare Solutions, Inc. is a medical technology company that works to bring new and innovative medical technologies to the market. The Company’s model is to engage a technology prior to its inflection point in order to maximize the profits available to EHSI as that new technology is adopted. Our common stock is traded under the symbol EHSI.

For more information, visit www.emerginghealthcaresolutionsinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts:

Emerging Healthcare Solutions, Inc.
Cindy Morrissey, 713-821-1486
President

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.